Literature DB >> 6991646

Plasma levodopa, dopamine and therapeutic response following levodopa therapy of Parkinsonian patients.

M N Rossor, J Watkins, M J Brown, J L Reid, C T Dollery.   

Abstract

In a double blind placebo controlled study of 6 Parkinsonian patients given a single dose of oral levodopa, the plasma levodopa and dopamine as measured by a radioenzymatic method both correlated with clinical improvement. There was a closer correlation with plasma dopamine than with plasma levodopa and it is proposed that peripheral decarboxylation may reflect central decarboxylation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6991646     DOI: 10.1016/0022-510x(80)90063-5

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

Review 1.  The on-off phenomenon.

Authors:  A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

2.  Clinical and pharmacokinetic comparison of oral and duodenal delivery of levodopa/carbidopa in patients with Parkinson's disease with a fluctuating response to levodopa.

Authors:  D Deleu; G Ebinger; Y Michotte
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  Infection of cultured striatal neurons with a defective HSV-1 vector: implications for gene therapy.

Authors:  A Freese; A Geller
Journal:  Nucleic Acids Res       Date:  1991-12       Impact factor: 16.971

Review 4.  Clinical pharmacokinetics of anti-parkinsonian drugs.

Authors:  J M Cedarbaum
Journal:  Clin Pharmacokinet       Date:  1987-09       Impact factor: 6.447

5.  Copper-mediated DNA damage by the neurotransmitter dopamine and L-DOPA: A pro-oxidant mechanism.

Authors:  Nida Rehmani; Atif Zafar; Hussain Arif; Sheikh Mumtaz Hadi; Altaf A Wani
Journal:  Toxicol In Vitro       Date:  2017-01-28       Impact factor: 3.500

Review 6.  Anti-parkinsonian drugs today.

Authors:  N P Quinn
Journal:  Drugs       Date:  1984-09       Impact factor: 9.546

7.  Parkinsonian abnormality of foot strike: a phenomenon of ageing and/or one responsive to levodopa therapy?

Authors:  J R Hughes; S G Bowes; A L Leeman; C J O'Neill; A A Deshmukh; P W Nicholson; S M Dobbs; R J Dobbs
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335

8.  Carbidopa-based modulation of the functional effect of the AAV2-hAADC gene therapy in 6-OHDA lesioned rats.

Authors:  Agnieszka Ciesielska; Nitasha Sharma; Janine Beyer; John Forsayeth; Krystof Bankiewicz
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.